Drug intelligence / Profile preview

budesonide + budesonide + formoterol

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Inhalation
01

Overview

This entry refers to a combination containing **two doses of budesonide** and **one dose of formoterol**. Budesonide is a synthetic corticosteroid that reduces lung inflammation, while formoterol is a long-acting β2-adrenergic agonist (LABA) that relaxes airway smooth muscle, leading to bronchodilation. These drugs are commonly used together to treat asthma and chronic obstructive pulmonary disease (COPD) via inhalation. However, the specific combination of "budesonide + budesonide + formoterol" (i.e., two discrete doses of budesonide plus one formoterol in a single inhaler or product) does not correspond to any widely recognized or marketed formulation; standard products contain a single dose of budesonide combined with formoterol, as in the fixed-dose combination found in products like Symbicort[1][2][3][4][5][6]. Therefore, this is either a misstatement or an uncommon formulation. Both components target different mechanisms to control airway inflammation and bronchospasm: budesonide acts as an anti-inflammatory agent, and formoterol as a bronchodilator.

Brand names
SymbicortSymbicort SMARTSymbicort Turbuhaler
Other names
budesonide/formoterolbudesonide/formoterol fumarate dihydrate
02

Targets

GR (Glucocorticoid receptor)ADRB2 (β2)

Beyond the preview

Go deeper on budesonide + budesonide + formoterol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on budesonide + budesonide + formoterol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call